Anders Olof Adolf Ekblom
Chairman at XSPRAY PHARMA AB
Net worth: 15 334 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Maris Gunars Hartmanis | M | 71 | 13 years | |
| Christine Lind | F | 50 | 9 years | |
| Uli Alf Hacksell | M | 74 | 6 years | |
| Bengt Westermark | M | 79 | 7 years | |
| Denise Goode | F | 66 |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | 9 years |
| Mathias Kjellberg | M | 53 |
Modul 1 Data AB
 Modul 1 Data AB Information Technology ServicesTechnology Services Modul 1 Data AB offers consulting and professional services. The firm provides knowledge-specific IT solutions and industry-specific business and eServices. Its IT consulting group develops, provides quality assurance and maintenance of business supporting IT solutions. The company was founded in 1991 and is headquartered in Stockholm, Sweden. | 25 years |
| Ahmed Hamdy | M | 59 | 11 years | |
| Per Andersson | M | 57 |
XSpray Pharma Futurum AB
| 18 years |
| Michael Wyzga | M | 69 | 5 years | |
| Tore Bengtsson | M | - |
Atrogi AB
 Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 11 years |
| Kerstin Hasselgren | F | 63 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 12 years |
| Laura Ila von Schantz | M | 42 | 10 years | |
| Thomas Bengt Eldered | M | 64 |
Flerie Invest AB
 Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | - |
| Carl-Johan Spak | M | 68 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden.
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | 9 years |
| Jeffrey Pott | M | - | 29 years | |
| Ulf Ljungberg | M | - |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | 13 years |
| Charles Sermon | M | 55 | 9 years | |
| Marc Dunoyer | M | 71 | 11 years | |
| Denise Scots-Knight | M | 64 | 9 years | |
| Anthon Jahreskog | M | 44 | 7 years | |
| Stig Lennart Hansson | M | 68 | 6 years | |
| Klas Kärre | M | 70 |
Karolinska Institutet
| - |
| Hans-Peter Albert Ostler | M | 53 | 3 years | |
| Erik Anders Kronström | M | 57 | 10 years | |
| Deepa Pakianathan | M | 59 | 5 years | |
| Andreas Bhagwani | M | 49 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 11 years |
| Magnus Sjoegren | M | - |
Karolinska Institutet
| 3 years |
| Eva Ulrika Sjökvist Saers | M | 62 | 3 years | |
| Kristina Sjöblom Nygren | M | 63 | 6 years | |
| Eva Idén | F | 58 | 7 years | |
| Marcus Wallenberg | M | 68 | 25 years | |
| Peter Ellmark | M | 51 | 6 years | |
| Anna Martling | M | 55 |
Karolinska Institutet
| - |
| Francesco Gatto | M | - |
Elypta AB
 Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | 7 years |
| Thomas Perlmann | M | - |
Karolinska Institutet
| - |
| Peter Sjöstrand | M | 78 |
Karolinska Institutet
| - |
| Karl Elmqvist | M | - |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | 3 years |
| Michael Owens | M | 68 | 9 years | |
| Marie Svensson | F | 60 | 4 years | |
| Bo Angelin | M | 73 |
Karolinska Institutet
| - |
| Gunilla Anders Ekström | M | 66 |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden.
Karolinska Institutet
| 21 years |
| Erna Möller | F | - |
Karolinska Institutet
| 9 years |
| Margareta Hagman | F | 58 | 9 years | |
| Pascal Soriot | M | 64 | 12 years | |
| Hans Lennart Rudolf Wigzell | M | 86 |
Karolinska Institutet
| 29 years |
| Jens Nielsen | M | - |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | 7 years |
| Göran Tornling | M | 77 |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden.
Karolinska Institutet
| - |
| John P. Richard | M | 66 | 9 years | |
| Staffan Encrantz | M | 72 |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | 2 years |
| Peter Helt Jacobsen Haahr | M | 56 |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | - |
| Rolf Valter Rikard Kiessling | M | 76 |
Karolinska Institutet
| 30 years |
| Jesper Mailind | M | 68 |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | 6 years |
| Franck Maréno | M | - |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | 6 years |
| Caroline Ingre | M | 47 |
Karolinska Institutet
| - |
| Carl Johan Bertil Sundberg | M | 66 |
Karolinska Institutet
| - |
| Christine Garrett | M | 53 |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | - |
| Cecilia Schéele | F | - |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | 3 years |
| Sumeet Ambarkhane | M | 56 | 2 years | |
| Søren Bregenholt | M | 53 | 3 years | |
| Peter Sackey | M | 53 |
Karolinska Institutet
| - |
| Ted Ingemar Jakob Fjällman | M | 46 |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | 5 years |
| Mårten Sundling | M | 53 |
Modul 1 Data AB
Modul 1 Data AB Information Technology ServicesTechnology Services Modul 1 Data AB offers consulting and professional services. The firm provides knowledge-specific IT solutions and industry-specific business and eServices. Its IT consulting group develops, provides quality assurance and maintenance of business supporting IT solutions. The company was founded in 1991 and is headquartered in Stockholm, Sweden. | 24 years |
| Ronald Li | M | - |
Karolinska Institutet
| 8 years |
| Erik Gustav Magnus Axelson | M | - |
Karolinska Institutet
| - |
| Lars Olov Larsson | M | - |
Karolinska Institutet
| - |
| Gunvor Ester Ekman-Ordeberg | M | 80 |
Karolinska Institutet
| 23 years |
| Magnus Westgren | M | 73 |
Karolinska Institutet
| 18 years |
| Anders Vahlne | M | 78 |
Karolinska Institutet
| 30 years |
| Lennart Hammarstrom | M | - |
Karolinska Institutet
| - |
| Paul Navarre | M | - |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | 2 years |
| Ralf Morgenstern | M | 72 |
Karolinska Institutet
| - |
| Eva Sjökvist Saers | M | 62 | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Simon Lowth | M | 62 | 6 years | |
| David Brennan | M | 70 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 13 years |
| Julie Brown | F | 62 | 14 years | |
| Gitte Pugholm Aabo | F | 57 |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | 27 years |
| Daniel Mackey | M | 50 | - | |
| Niklas Prager | M | 54 | 3 years | |
| Alastair MacKinnon | M | 53 | 7 years | |
| Rein Piir | M | 66 | 17 years | |
| Jane M. Birgitta Stymne Göransson | F | 67 |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | 3 years |
| Lilian Birgitta Wikström | M | 63 | 7 years | |
| Catherine Mazzacco | F | 59 |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | 2 years |
| Richard Bungay | M | 55 | 2 years | |
| Peter John Fellner | M | 80 | 7 years | |
| Leif Valdemar Johansson | M | 73 | 11 years | |
| Peter James Arthur Benson | M | 69 | 10 years | |
| Marie Helena Levander | F | 67 | 6 years | |
| Graham Dixon | M | 63 | 14 years | |
| Nils-Göran Pettersson | M | 79 | 6 years | |
| Julie Silber | F | 56 | - | |
| Per Norlén | M | 54 | 11 years | |
| Jukka Pekka Pertola | M | 64 |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | 8 years |
| Anna Ulrika Danielsson | F | 52 | 5 years | |
| Lennart Erik Jonas Sjögren | M | 58 | 6 years | |
| David Smith | M | - | 9 years | |
| Karl Arne Krister Borrebaeck | M | 76 | 20 years | |
| Kenth Ingemar Petersson | M | 68 | 20 years | |
| Frank Armstrong | M | 67 | 4 years | |
| Charlotte Elisabet Edenius | M | 66 | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 70 | 70.00% |
| United Kingdom | 30 | 30.00% |
| Denmark | 9 | 9.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Anders Olof Adolf Ekblom
- Personal Network
